Kubík A, Zatloukal P, Kríz J
Klinika pneumologie a hrudní chirurgie 2. LF UK a FN Na Bulovce, Praha.
Cas Lek Cesk. 1999 May 10;138(10):310-5.
Lung cancer is the leading cause of cancer deaths worldwide, with considerable geographical variation. In the Czech Republic, the male population experienced the highest lung cancer mortality rates in the mid-80s, ranking with the top mortality rates in Europe. Since that time, notable changes in time trends, widely different for men and women, were observed. The objective of the work is to analyze the trends in lung cancer mortality in the Czech Republic over the last 45 years, to estimate the prediction of the trends for the next decade, and consider the results of some recent surveys informing on the smoking patterns of the Czech population.
Standardized mortality from lung cancer in Czech men increased from 22.3/100,000 in 1950 to 79.8 in 1986, and decreased to 69.7 in 1995 (world standard). In the female population: 4.3/100,000 in 1950, 8.5 in 1986, and 11.6 in 1995, respectively. Using a log-linear Poisson regression model, a decrease to 68.0/100,000 for men, and an increase to 16.1 for women by the end of the next decade has been predicted. Some decreases in the age-specific lung cancer mortality rates were observed in young adult men, and, for the next decade, similar trends have been predicted for middle-aged men. In the female population, the trends have been rising in all age groups. There was an increase in the cigarette consumption in the Czech Republic from 1731 cigarettes per 1 inhabitant aged 15 years and older in 1953 to 2552 cigarettes in 1978, and a subsequent decrease to 2279 cigarettes in 1989. The prevalence of smoking in six Czech districts participating in the MONICA project (25) had a downward trend in men aged 25-64 years during the period 1985-1992, whereas no significant changes in smoking prevalence were observed for women.
In the recent phase of the lung cancer epidemic in the Czech Republic, a turn for the better has been taken in men: a decreasing trend in standardized lung cancer mortality was observed since the late 1980s, and its continuation up to 2009 has been predicted (on the average, by -0.7% annually). Conversely, in the female population, further increases in lung cancer mortality can be expected for the next decade (by 3.1% annually). Consequently, a comprehensive control of smoking in women appears to be a priority in lung cancer prevention. Moreover, further studies in the role of potential cofactors affecting the incidence of lung cancer in women deserve attention.
肺癌是全球癌症死亡的主要原因,存在显著的地域差异。在捷克共和国,男性人口在80年代中期经历了最高的肺癌死亡率,在欧洲死亡率排名靠前。自那时以来,观察到时间趋势发生了显著变化,男性和女性的变化差异很大。这项工作的目的是分析捷克共和国过去45年肺癌死亡率的趋势,估计未来十年的趋势预测,并考虑一些最近关于捷克人口吸烟模式的调查结果。
捷克男性肺癌标准化死亡率从1950年的22.3/10万上升到1986年的79.8,1995年降至69.7(世界标准)。女性人口中,1950年为4.3/10万,1986年为8.5,1995年为11.6。使用对数线性泊松回归模型预测,到下一个十年末,男性将降至68.0/10万,女性将升至16.1。在年轻成年男性中观察到特定年龄组肺癌死亡率有所下降,预计未来十年中年男性也会有类似趋势。在女性人口中,所有年龄组的趋势都在上升。捷克共和国的香烟消费量从1953年每15岁及以上居民1731支增加到1978年的2552支,随后在1989年降至2279支。参与莫尼卡项目(25)的六个捷克地区的吸烟率在1985 - 1992年期间,25 - 64岁男性呈下降趋势,而女性吸烟率没有显著变化。
在捷克共和国肺癌流行的最近阶段,男性情况有所好转:自20世纪80年代末以来观察到标准化肺癌死亡率呈下降趋势,并预计持续到2009年(平均每年下降0.7%)。相反,在女性人口中,预计未来十年肺癌死亡率将进一步上升(每年上升3.1%)。因此,全面控制女性吸烟似乎是肺癌预防的优先事项。此外,影响女性肺癌发病率的潜在辅助因素的作用值得进一步研究关注。